Genetic Association of Glutathione Peroxidase-1 with Coronary Artery Calcification in Type 2 Diabetes: a Case Control Study with Multi-slice Computed Tomography

Overview

Journal Cardiovasc Diabetol

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
Endocrinology

Date 2007 Sep 11

PMID 17825092

Citations 31

Authors

Masami Nemoto

Rimei Nishimura

Takashi Sasaki

Yoshito Hiki

Yumi Miyashita

Makiko Nishioka

Kei Fujimoto

Toru Sakuma

Toya Ohashi

Kunihiko Fukuda

Yoshikatsu Eto

Naoko Tajima

Affiliations

Soon will be listed here.

Abstract

Background: Although oxidative stress by accumulation of reactive oxygen species (ROS) in diabetes has become evident, it remains unclear what genes, involved in redox balance, would determine susceptibility for development of atherosclerosis in diabetes. This study evaluated the effect of genetic polymorphism of enzymes producing or responsible for reducing ROS on coronary artery calcification in type 2 diabetes (T2D).

Methods: An index for coronary-arteriosclerosis, coronary artery calcium score (CACS) was evaluated in 91 T2D patients using a multi-slice computed tomography. Patients were genotyped for ROS-scavenging enzymes, Glutathione peroxidase-1 (GPx-1), Catalase, Mn-SOD, Cu/Zn-SOD, as well as SNPs of NADPH oxidase as ROS-promoting elements, genes related to onset of T2D (CAPN10, ADRB3, PPAR gamma, FATP4). Age, blood pressure, BMI, HbA1c, lipid and duration of diabetes were evaluated for a multivariate regression analysis.

Results: CACS with Pro/Leu genotype of the GPx-1 gene was significantly higher than in those with Pro/Pro (744 +/- 1,291 vs. 245 +/- 399, respectively, p = 0.006). In addition, genotype frequency of Pro/Leu in those with CACS >or= 1000 was significantly higher than in those with CACS < 1000 (45.5% vs. 18.8%; OR = 3.61, CI = 0.97-13.42; p = 0.045) when tested for deviation from Hardy-Weinberg's equilibrium. Multivariate regression analyses revealed that CACS significantly correlated with GPx-1 genotypes and age.

Conclusion: The presence of Pro197Leu substitution of the GPx-1 gene may play a crucial role in determining genetic susceptibility to coronary-arteriosclerosis in T2D. The mechanism may be associated with a decreased ability to scavenge ROS with the variant GPx-1.

Citing Articles

Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and Melatonin.

Theofilis P, Vordoni A, Kalaitzidis R Life (Basel). 2022; 12(10).

PMID: 36295098 PMC: 9605243. DOI: 10.3390/life12101663.

New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors.

Busa P, Kuthati Y, Huang N, Wong C Front Pharmacol. 2022; 13:864088.

PMID: 35496279 PMC: 9039240. DOI: 10.3389/fphar.2022.864088.

Contribution of glutathione peroxidase 1 (Pro200Leu) single nucleotide polymorphism and serum homocysteine levels in the risk of acute myocardial infarction in Egyptians.

Ismail L, Abdel Rahman M, Hashad I, Abdel-Maksoud S J Genet Eng Biotechnol. 2022; 20(1):21.

PMID: 35138466 PMC: 8828810. DOI: 10.1186/s43141-022-00307-6.

Progress in the emerging role of selenoproteins in cardiovascular disease: focus on endoplasmic reticulum-resident selenoproteins.

Rocca C, Pasqua T, Boukhzar L, Anouar Y, Angelone T Cell Mol Life Sci. 2019; 76(20):3969-3985.

PMID: 31218451 PMC: 11105271. DOI: 10.1007/s00018-019-03195-1.

Genetic Polymorphisms of Catalase and Glutathione Peroxidase-1 in Keratoconus.

Yari D, Saravani R, Saravani S, Ebrahimian K, Galavi H Iran J Public Health. 2018; 47(10):1567-1574.

PMID: 30524988 PMC: 6277734.

References

McClung J, Roneker C, Mu W, Lisk D, Langlais P, Liu F . Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc Natl Acad Sci U S A. 2004; 101(24):8852-7. PMC: 428436. DOI: 10.1073/pnas.0308096101. View

Gertow K, Bellanda M, Eriksson P, Boquist S, Hamsten A, Sunnerhagen M . Genetic and structural evaluation of fatty acid transport protein-4 in relation to markers of the insulin resistance syndrome. J Clin Endocrinol Metab. 2004; 89(1):392-9. DOI: 10.1210/jc.2003-030682. View

Blankenberg S, Rupprecht H, Bickel C, Torzewski M, Hafner G, Tiret L . Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med. 2003; 349(17):1605-13. DOI: 10.1056/NEJMoa030535. View

Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K . Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke. 2003; 34(10):2349-54. DOI: 10.1161/01.STR.0000090348.52943.A2. View

Nomiyama T, Tanaka Y, Piao L, Nagasaka K, Sakai K, Ogihara T . The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet. 2003; 48(3):138-41. DOI: 10.1007/s100380300021. View

Forgione M, Weiss N, Heydrick S, Cap A, Klings E, Bierl C . Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2002; 282(4):H1255-61. DOI: 10.1152/ajpheart.00598.2001. View

Fu Y, Porres J, Lei X . Comparative impacts of glutathione peroxidase-1 gene knockout on oxidative stress induced by reactive oxygen and nitrogen species in mouse hepatocytes. Biochem J. 2001; 359(Pt 3):687-95. PMC: 1222191. DOI: 10.1042/0264-6021:3590687. View

Jiang Z, Akey J, Shi J, Xiong M, Wang Y, Shen Y . A polymorphism in the promoter region of catalase is associated with blood pressure levels. Hum Genet. 2001; 109(1):95-8. DOI: 10.1007/s004390100553. View

Ukkola O, Erkkila P, Savolainen M, Kesaniemi Y . Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med. 2001; 249(5):451-9. DOI: 10.1046/j.1365-2796.2001.00828.x. View

10.

Hamanishi T, Furuta H, Kato H, Doi A, Tamai M, Shimomura H . Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in japanese type 2 diabetic patients. Diabetes. 2004; 53(9):2455-60. DOI: 10.2337/diabetes.53.9.2455. View

11.

Oda N, Cox N, Li X, Orho-Melander M, Hara M, Hinokio Y . Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 2000; 26(2):163-75. DOI: 10.1038/79876. View

12.

Ohnuki K, Yoshida S, Ohta M, Shimizu M, Mochizuki S, Nishioka M . New diagnostic technique in multi-slice computed tomography for in-stent restenosis: pixel count method. Int J Cardiol. 2005; 108(2):251-8. DOI: 10.1016/j.ijcard.2005.05.013. View

13.

Anand D, Lim E, Hopkins D, Corder R, Shaw L, Sharp P . Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J. 2006; 27(6):713-21. DOI: 10.1093/eurheartj/ehi808. View

14.

Johansen J, Harris A, Rychly D, Ergul A . Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol. 2005; 4:5. PMC: 1131912. DOI: 10.1186/1475-2840-4-5. View

15.

Leopold J, Loscalzo J . Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol. 2005; 25(7):1332-40. DOI: 10.1161/01.ATV.0000163846.51473.09. View

16.

Schnabel R, Lackner K, Rupprecht H, Espinola-Klein C, Torzewski M, Lubos E . Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study. J Am Coll Cardiol. 2005; 45(10):1631-7. DOI: 10.1016/j.jacc.2005.02.053. View

17.

Forsberg L, de Faire U, Morgenstern R . Low yield of polymorphisms from EST blast searching: analysis of genes related to oxidative stress and verification of the P197L polymorphism in GPX1. Hum Mutat. 1999; 13(4):294-300. DOI: 10.1002/(SICI)1098-1004(1999)13:4<294::AID-HUMU6>3.0.CO;2-5. View

18.

Deeb S, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J . A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998; 20(3):284-7. DOI: 10.1038/3099. View

19.

Cheng W, Ho Y, Valentine B, Ross D, Combs Jr G, Lei X . Cellular glutathione peroxidase is the mediator of body selenium to protect against paraquat lethality in transgenic mice. J Nutr. 1998; 128(7):1070-6. DOI: 10.1093/jn/128.7.1070. View

20.

Walston J, Silver K, Bogardus C, Knowler W, Celi F, Austin S . Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med. 1995; 333(6):343-7. DOI: 10.1056/NEJM199508103330603. View